Ryan Smith

Ryan Smith is founder of TruDiagnsotic. TruDiagnostic is a CLIA certified lab and health data company which specializes in understanding and reporting insights found through Epigenetic methylation data. Since starting in 2020, TruDiagnostic has created the largest private epigenetic database in the world with over 200,000 patients tested. From this dataset, they have created many new algorithms to interpret methylation data including algorithms to predict inflammatory markers, disease diagnosis, telomere length, aging pace, immune cell subsets, cellular replication, and more. TruDiagnostics has also led research in the field with over 70+ clinical trials investigating the best ways to reverse these markers through diet, lifestyle, and prescription interventions. Currently, TruDiagnostic is working with collaborators from Duke, Harvard, Yale, Stanford, and more to uncover new insights from the methylome.

Prior to founding TruDiagnostic, Ryan founded Tailor Made Compounding and the International Peptide Society which focused on bringing peptides to market in the US.